ALX Oncology (NASDAQ:ALXO) PT Raised to $17.50 at HC Wainwright
ALX Oncology (NASDAQ:ALXO – Get Free Report) had its target price upped by investment analysts at HC Wainwright from $16.00 to $17.50 in a report released on Tuesday, MarketBeat reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 174.29% from the stock’s current […]